EDGAR Filing Documents for 0001564590-17-014324

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001564590-17-014324

Filing Date

2017-07-28

Accepted

2017-07-27 18:42:34

Documents

Period of Report

2017-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	10-Q	rare-10q_20170630.htm	10-Q	1648785
2	EX-1.1	rare-ex11_260.htm	EX-1.1	235337
3	EX-5.1	rare-ex51_346.htm	EX-5.1	8851
4	EX-31.1	rare-ex311_8.htm	EX-31.1	17412
5	EX-31.2	rare-ex312_6.htm	EX-31.2	17490
6	EX-32.1	rare-ex321_7.htm	EX-32.1	10799
7	GRAPHIC	g201707272216359995570.jpg	GRAPHIC	44172
8	GRAPHIC	g201707272216133475196.jpg	GRAPHIC	89690
9	GRAPHIC	g201707272216134375196.jpg	GRAPHIC	18360
	Complete submission text file	0001564590-17-014324.txt		4972454

Data Files

Seq	Description	Document	Type	Size
10	XBRL INSTANCE DOCUMENT	rare-20170630.xml	EX-101.INS	859365
11	XBRL TAXONOMY EXTENSION SCHEMA	rare-20170630.xsd	EX-101.SCH	32419
12	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	rare-20170630_cal.xml	EX-101.CAL	37622
13	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	rare-20170630_def.xml	EX-101.DEF	84155
14	XBRL TAXONOMY EXTENSION LABEL LINKBASE	rare-20170630_lab.xml	EX-101.LAB	234582
15	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	rare-20170630_pre.xml	EX-101.PRE	167699

Mailing Address 60 LEVERONI COURT NOVATO CA 94949

Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800

Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)